Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan.

Source:http://linkedlifedata.com/resource/pubmed/id/17382251

Download in:

View as

General Info

PMID
17382251